These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20966112)

  • 1. System-wide effects of Global Fund investments in Nepal.
    Trägård A; Shrestha IB
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i58-62. PubMed ID: 20966112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical interactions between Global Fund-supported programmes and health systems: a case study in Thailand.
    Hanvoravongchai P; Warakamin B; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i53-57. PubMed ID: 20966111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical interactions between Global Fund-supported programmes and health systems: a case study in Indonesia.
    Desai M; Rudge JW; Adisasmito W; Mounier-Jack S; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i43-47. PubMed ID: 20966109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
    Mounier-Jack S; Rudge JW; Phetsouvanh R; Chanthapadith C; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i37-42. PubMed ID: 20966107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical interactions between Global Fund-supported programmes and health systems: a case study in Papua New Guinea.
    Rudge JW; Phuanakoonon S; Nema KH; Mounier-Jack S; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i48-52. PubMed ID: 20966110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of health systems and priority health interventions: a case study of the integration of HIV and TB control programmes into the general health system in Vietnam.
    Conseil A; Mounier-Jack S; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i32-36. PubMed ID: 20966106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When do vertical programmes strengthen health systems? A comparative assessment of disease-specific interventions in India.
    Rao KD; Ramani S; Hazarika I; George S
    Health Policy Plan; 2014 Jul; 29(4):495-505. PubMed ID: 23749734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global fund financing of tuberculosis services delivery in prisons.
    Lee D; Lal SS; Komatsu R; Zumla A; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S274-83. PubMed ID: 22448026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical interactions between the Global Fund-supported HIV programs and the health system in Ghana.
    Atun R; Pothapregada SK; Kwansah J; Degbotse D; Lazarus JV
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S72-6. PubMed ID: 21857300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].
    Ishikawa N
    Kekkaku; 2005 Feb; 80(2):89-94. PubMed ID: 15920981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. France and Japan increase support for Global Fund; a new leader is appointed.
    Watson R
    BMJ; 2012 Mar; 344():e2315. PubMed ID: 22451480
    [No Abstract]   [Full Text] [Related]  

  • 15. Start-stop funding, its causes and consequences: a case study of the delivery exemptions policy in Ghana.
    Witter S; Adjei S
    Int J Health Plann Manage; 2007; 22(2):133-43. PubMed ID: 17623355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How health systems in sub-Saharan Africa can benefit from tuberculosis and other infectious disease programmes.
    Harries AD; Jensen PM; Zachariah R; Rusen ID; Enarson DA
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1194-9. PubMed ID: 19793422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Fund financing of public-private mix approaches for delivery of tuberculosis care.
    Lal SS; Uplekar M; Katz I; Lonnroth K; Komatsu R; Yesudian Dias HM; Atun R
    Trop Med Int Health; 2011 Jun; 16(6):685-92. PubMed ID: 21332892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking programmes and systems: lessons from the GAVI Health Systems Strengthening window.
    Galichet B; Goeman L; Hill PS; Essengue MS; Hammami N; Porignon D; Kadama P; Van Lerberghe W
    Trop Med Int Health; 2010 Feb; 15(2):208-15. PubMed ID: 20002617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.